Germany’s Institute for Quality and Efficiency in Health Care concluded that Columvi (glofitamab) monotherapy shows no added ...

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies (Nasdaq: ADPT) said Monday that its strategic ...

The US regulator has issued draft guidance urging drug developers to prioritize overall survival as the primary endpoint in ...

Heidelberg, Germany-based research institute BioMed X announced a new collaboration with Denmark’s Novo Nordisk, which aims ...

Shares of San Diego, USA-based Viking Therapeutics tumbled 43% to $23.50 by mid-morning after the company released mid-stage ...

In a significant shift for the US pharmaceutical landscape, President Donald Trump has formally announced in May 2025, a push ...

Australian biotech CSL Limited today reported net profit after tax of US$3.0 billion for the 12 months ended June 30, 2025, ...

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

Shanghai Henlius Biotech today revealed it has entered into a strategic collaboration with fellow Chinese drug developer ...

Privately-held US biotech Skyhawk Therapeutics has announced a strategic research collaboration with Germany’s Merck KGaA ...

Clinical research provider IQVIA and Veeva System have announced global clinical and commercial partnerships and the complete ...